<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01338467</url>
  </required_header>
  <id_info>
    <org_study_id>EYEMUST</org_study_id>
    <secondary_id>2011-A00196-35</secondary_id>
    <nct_id>NCT01338467</nct_id>
  </id_info>
  <brief_title>Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device</brief_title>
  <official_title>Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound (HIFU). A Prospective, Multicenter, Open-label, Safety and Efficacy Study of the Treatment With the EYEOP Medical Device in Patients With Refractory Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EyeTechCare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EyeTechCare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the effectiveness and the safety of the EYEOP treatment
      using High Intensity Focused Ultrasound in refractory glaucoma patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary efficacy measure :</measure>
    <time_frame>6 months</time_frame>
    <description>IOP change (mmHg and Percent) from baseline to 6 months post-HIFU treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety measures</measure>
    <time_frame>6 months</time_frame>
    <description>The incidence of device and procedure-related complications during the follow-up</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>EYEOP Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Open label, all subject treated by the EYEOP device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EYEOP device</intervention_name>
    <description>Cyclocoagulation using High Intensity Focused Ultrasound with EYEOP device</description>
    <arm_group_label>EYEOP Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary open angle glaucoma included pseudo-exfoliative glaucoma and pigmentary
             glaucoma in the study eye with maximally tolerated medical treatment

          -  Ocular hypertension defined as an intraocular pressure (IOP) &gt; 21 mm Hg

          -  Subject has failed a conventional intraocular glaucoma filtering surgery

          -  Patient must be aged 18 years or more

          -  No previous intraocular glaucoma surgery or laser treatment in the study eye during
             the 3 months before HIFU treatment

          -  No previous cyclophotocoagulation procedure in the study eye

          -  Patient able and willing to provide informed consent and to complete post-operative
             follow-up requirements.

        Exclusion Criteria:

          -  History of previous glaucoma surgery with implantation of glaucoma drainage device in
             the study eye

          -  History of ocular or retrobulbar tumor

          -  Retinal detachment, choroidal hemorrhage or detachment

          -  Ocular infectious disease within 14 days before HIFU treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe DENIS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Croix Rousse Hospital - Lyon - France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laurent FARCY</last_name>
    <role>Study Director</role>
    <affiliation>EyeTechCare</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Florent APTEL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital - Grenoble - France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital - Cl Huriez</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique du Parc - Private Hospital</name>
      <address>
        <city>Lyon</city>
        <zip>69006</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Croix Rousse Hospital</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>XV-XX National Ophthalmologic Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>XV-XX Ophthalmologic Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint-Joseph Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Val de Grace Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75235</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Denis P, Aptel F, Rouland JF, Nordmann JP, Lachkar Y, Renard JP, Sellem E, Baudouin C, Bron A. Cyclocoagulation of the ciliary bodies by high-intensity focused ultrasound: a 12-month multicenter study. Invest Ophthalmol Vis Sci. 2015 Jan 20;56(2):1089-96. doi: 10.1167/iovs.14-14973.</citation>
    <PMID>25604688</PMID>
  </results_reference>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2011</study_first_submitted>
  <study_first_submitted_qc>April 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 19, 2011</study_first_posted>
  <last_update_submitted>June 15, 2015</last_update_submitted>
  <last_update_submitted_qc>June 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glaucoma</keyword>
  <keyword>Refractory glaucoma</keyword>
  <keyword>Cyclocoagulation</keyword>
  <keyword>High Intensity Focused Ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

